What antibiotics are in the same family as cephalexin, a first-generation cephalosporin (cephalosporin) antibiotic?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cephalexin Family: First-Generation Cephalosporins

Cephalexin belongs to the first-generation cephalosporin family, and other antibiotics in this same class include cefadroxil, cefazolin, cephalothin, and cefprozil. 1, 2

First-Generation Cephalosporins (Same Family as Cephalexin)

Oral Agents

  • Cefadroxil: This is the most closely related oral first-generation cephalosporin to cephalexin, with identical MIC distributions (MIC50 of 2 μg/mL and MIC90 of 4 μg/mL against MSSA) 3
  • Cefadroxil offers the advantage of less frequent dosing (500 mg twice daily) compared to cephalexin (500 mg 2-3 times daily) due to slower renal clearance 4
  • Cephalexin and cefadroxil are both recommended by WHO as first-choice antibiotics for mild skin and soft tissue infections 5

Parenteral Agents

  • Cefazolin: A first-generation parenteral cephalosporin with a unique R1 side chain that distinguishes it from other members of this class 1
  • Cephalothin: Another parenteral first-generation agent with similar antimicrobial spectrum 3

Structural Relationship and Cross-Reactivity

Shared Chemical Structure

  • All cephalosporins, including first-generation agents, share a bicyclic ring system (nucleus) that differs from penicillins in structure 2
  • Cephalexin specifically has a D-phenylglycyl group at the 7-amino position and an unsubstituted methyl group at the 3-position 2

Important Cross-Reactivity Pattern

  • Aminocephalosporins (cephalexin, cefadroxil, cefprozil, cefaclor) share the R1 side chain with aminopenicillins, resulting in a 16.45% cross-reactivity risk (95% CI: 11.07-23.75) in patients with confirmed penicillin allergy 1, 6
  • In contrast, cefazolin has very low cross-reactivity with penicillins despite being a first-generation cephalosporin, with only 0.8% reaction rate (95% CI: 0.13%-4.1%) among confirmed penicillin-allergic patients 1

Clinical Spectrum Characteristics

Antimicrobial Activity Pattern

  • First-generation cephalosporins are most potent against Gram-positive cocci (especially Staphylococcus aureus and Streptococcus species) but have limited Gram-negative coverage 7, 8
  • They are bactericidal against most clinically important gram-positive cocci and some gram-negative bacilli 8
  • None of the cephalosporins, including first-generation agents, have activity against enterococci 8

Common Clinical Applications

  • Surgical prophylaxis and treatment of staphylococcal/streptococcal infections in penicillin-allergic patients 8
  • Mild skin and soft tissue infections caused by gram-positive cocci 5, 6
  • Upper respiratory tract infections (except those caused by Haemophilus influenzae, where failure rates reach 50%) 9

Important Caveat

Avoid using cephalexin or other aminocephalosporins (cefadroxil, cefprozil) in patients with a history of anaphylaxis, angioedema, or urticaria to penicillins or ampicillin due to the shared R1 side chain and significant cross-reactivity risk 6. In such cases, cefazolin would be a safer first-generation cephalosporin alternative if this class is required 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.